Search

everythinglearnresearchcommunity

for

Search:↓

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

FUE and SMP together can effectively treat hair loss, needing fewer procedures.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Finasteride improves hair loss in women with hyperandrogenism.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Male pattern baldness may predict prostate cancer risk.

Most patients with hair loss sought treatment for cosmetic reasons, were unhappy about their appearance, and had a family history of the condition, suggesting it may be inherited.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Surgeons need to understand natural hair patterns for better hair restoration results.

Bald men are often viewed more negatively and as older than they really are.

Michael L. Beehner proposed a standardized way to describe balding areas on the scalp to help hair restoration experts communicate better.

Short scalp flaps are easier but not good for severe baldness; Juri flaps are complex but better for density and coverage.

Children's hairlines change shape as they grow, with women often developing a widow's peak and men's hairlines becoming more convex and possibly balding at the temples, influenced by genetics and hormones.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

Commercial hair loss websites promote Propecia by making men feel insecure about baldness and suggesting it's a medical issue needing treatment.

The hair follicle is a great model for research to improve hair growth treatments.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Androgenetic alopecia (AGA) is a common, hereditary hair loss condition that can be slowed but not permanently reversed with available therapies.

Genes and hormones cause hair loss, with four genes contributing equally.

Researchers created a new system to classify male baldness, finding six types and a common hairline shape, to improve hair loss treatments.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

There's no significant genetic link between male pattern baldness and COVID-19.

Lowest effective minoxidil concentration is 1%, but 2% works better for male pattern baldness.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

AGA more common in men, Koreans have lower rates and unique patterns.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Treating hair loss in both men and women is effective and improves quality of life.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.